Global University Venturing

Spun out of University of Nantes and research institute Inserm, GoLiver Therapeutics hopes to catalyse a stem cell-based regenerative drug candidate for the treatment of acute and chronic severe liver failure.

Dicronis hopes its microneedle-based device will help clinicians catch impairments in cancer patients’ lymphatic network that cause chronic swelling in the legs, arm of chest.

Founded on inventions from Centre for Quantum Technologies, Speqtral is now set to commercialise its first application for quantum communications satellites.

Cambridge Innovation Capital is in line for an exit as oncology drug developer Bicycle Therapeutics prepares to float, having filed to raise $86m in its IPO.

More than six years after being launched by Open University to offer massive open online courses, FutureLearn has raised its first external funding from Seek Group.

France’s 13 regional tech transfer offices have now launched 370 spinouts since 2012, after adding another 112 new companies last year.

Amgen is among the seed investors for Stanford-licensed drug release technology developer Navan Technologies, which hopes its nanoinjection technique will enable more cell and gene therapies to be produced at scale.

Allied Minds will focus on funding existing companies after exiting the red to bank a $47.3m net profit for 2018.

University of Nottingham spinouts amassed a record return for the university’s equity management division in 2018, with a share of the haul earmarked for further high-impact research.

Chris Downing will stand aside as vice-president and director of Georgia Tech’s Enterprise Innovation Institute, drawing the curtain on more than three decades at Georgia Tech.

Global University Venturing will reveal the winners of this year's awards at the gala dinner as part of GUV: Fusion on May 22.